Yesterday, March 21, 2016, 70 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $28.00 to $5,401,379.46.

Highlighted Stocks Traded by Insiders:

Gevo (GEVO) - FREE Research Report

Ryan Christopher Michael, who is President and COO at Gevo, sold 70 shares at $0.40 on March 21, 2016. Following this transaction, the President and COO owned 34,104 shares meaning that the stake was reduced by 0.2% with the 70-share transaction.

The shares most recently traded at $0.38, down $0.02, or 5.26% since the insider transaction. Historical insider transactions for Gevo go as follows:

  • 4-Week # shares bought: 181,484
  • 4-Week # shares sold: 618
  • 12-Week # shares bought: 181,484
  • 12-Week # shares sold: 4,991
  • 24-Week # shares bought: 181,484
  • 24-Week # shares sold: 7,394

The average volume for Gevo has been 355,100 shares per day over the past 30 days. Gevo has a market cap of $6.4 million and is part of the basic materials sector and chemicals industry. Shares are down 40.05% year-to-date as of the close of trading on Monday.

Gevo, Inc., a renewable chemicals and biofuels company, focuses on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The company operates in two segments, Gevo, Inc.; and Gevo Development/Agri-Energy. Currently, there is 1 analyst who rates Gevo a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on GEVO - FREE

TheStreet Quant Ratings rates Gevo as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and generally disappointing historical performance in the stock itself. Get the full Gevo Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Teradyne (TER) - FREE Research Report

Bradley Michael A, who is Director at Teradyne, sold 34,000 shares at $20.91 on March 21, 2016. Following this transaction, the Director owned 152,386 shares meaning that the stake was reduced by 18.24% with the 34,000-share transaction.

The shares most recently traded at $21.38, up $0.47, or 2.19% since the insider transaction. Historical insider transactions for Teradyne go as follows:

  • 4-Week # shares sold: 14,594
  • 12-Week # shares sold: 14,594
  • 24-Week # shares sold: 14,594

The average volume for Teradyne has been 2.1 million shares per day over the past 30 days. Teradyne has a market cap of $4.3 billion and is part of the technology sector and electronics industry. Shares are up 3.1% year-to-date as of the close of trading on Monday.

Teradyne, Inc. designs, develops, manufactures, and sells automatic test equipment worldwide. The stock currently has a dividend yield of 1.15%. The company has a P/E ratio of 21.4. Currently, there are 5 analysts who rate Teradyne a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TER - FREE

TheStreet Quant Ratings rates Teradyne as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and notable return on equity. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Teradyne Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Tiptree Financial (TIPT) - FREE Research Report

Barnes Michael Gene, who is Executive Chairman at Tiptree Financial, bought 5,000 shares at $5.92 on March 21, 2016. Following this transaction, the Executive Chairman owned 3.4 million shares meaning that the stake was boosted by 0.15% with the 5,000-share transaction.

The shares most recently traded at $5.70, down $0.22, or 3.86% since the insider transaction. Historical insider transactions for Tiptree Financial go as follows:

  • 4-Week # shares bought: 39,690
  • 4-Week # shares sold: 26,878
  • 12-Week # shares bought: 122,621
  • 12-Week # shares sold: 135,332
  • 24-Week # shares bought: 261,267
  • 24-Week # shares sold: 135,332

The average volume for Tiptree Financial has been 82,700 shares per day over the past 30 days. Tiptree Financial has a market cap of $254.7 million and is part of the financial sector and insurance industry. Shares are down 5.05% year-to-date as of the close of trading on Monday.

TipTree Financial Inc., formerly Care Investment Trust, operates as a real estate investment trust (REIT). It engages in originating and acquiring healthcare-related real estate and commercial mortgage debt. The stock currently has a dividend yield of 1.71%.

Exclusive Offer: Get the latest Stock Analysis on TIPT - FREE

TheStreet Quant Ratings rates Tiptree Financial as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally high debt management risk, disappointing return on equity, poor profit margins and generally disappointing historical performance in the stock itself. Get the full Tiptree Financial Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.